THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Monday reported a loss of $3.4 million in its fourth quarter.
The Thousand Oaks, California-based company said it had a loss of 25 cents per share.
The drug developer posted revenue of $1.6 million in the period.
For the year, the company reported net income of $32.7 million, or $2.57 per share, swinging to a profit in the period. Revenue was reported as $120.8 million.
Atara Biotherapeutics shares have declined 68% since the beginning of the year. In the final minutes of trading on Monday, shares hit $5.87, a decline of 19% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
